The Harvard surgeon, writer, and professor who ran(#before 2020-05-11 16:40:00) the Amazon-JPMorgan-Berkshire Hathaway health venture is set(#included now) to step(#before 2020-05-11 16:40:00) down, and now they're looking(#included now) for a new CEO .
2020-05-11 16:40:00 +00:00 .
Dr. Atul Gawande , the surgeon , professor , and writer who 's been the CEO of Haven for nearly two years is in talks(#overlap 2020-05-11 16:40:00) to step(#before 2020-05-11 16:40:00) away from the role , according to a person familiar with talks .
Haven is JPMorgan , Berkshire Hathaway , and Amazon 's healthcare joint venture(#included May 2019) that was established(#included May 2019) in January 2018.It'd be the second top departure(#included May 2019) for the Amazon-JPMorgan-Berkshire Hathaway health venture since launching(#before 2020-05-11 16:40:00) .
Chief Operating Officer Jack Stoddard left(#included May 2019) in May 2019 .
the Amazon-JPMorgan-Berkshire Hathaway health venture has since hired(#before 2020-05-11 16:40:00) a new COO , according to a source familiar with hired .
Visit Business Insider 's homepage for more stories .
a new COO is in talks(#overlap 2020-05-11 16:40:00) to step(#before 2020-05-11 16:40:00) down from the role , according to a source familiar with the discussions .
Instead , Dr. Atul Gawande , the surgeon and writer who 's been CEO of Amazon , JPMorgan , and Berkshire Hathaway 's joint health venture for nearly two years would take(#after 2020-05-11 16:40:00) on a chairman role at Haven , giving(#included now) Dr. Atul Gawande , the surgeon and writer who 's been CEO of Amazon , JPMorgan , and Berkshire Hathaway 's joint health venture for nearly two years more time to focus(#after 2020-05-11 16:40:00) on work related to the coronavirus pandemic(#before 2020-05-11 16:40:00) , The Wall Street Journal reported(#included Friday) Friday .
take 'd be the second top executive departure(#included May 2019) for the Amazon-JPMorgan-Berkshire Hathaway health venture , following(#included May 2019) the May 2019 exit(#included May 2019) of Chief Operating Officer Jack Stoddard .
the Amazon-JPMorgan-Berkshire Hathaway health venture has hired(#before 2020-05-11 16:40:00) a new chief operating officer , who has yet to be publicly announced(#before 2020-05-11 16:40:00) , according to a source familiar with the discussions .
In January 2018 , Amazon , JPMorgan , and Berkshire announced(#included January 2018) that Amazon , JPMorgan , and Berkshire would create(#included January 2018) a healthcare joint venture that 's geared toward lowering healthcare costs for the companies ' employees and improving the quality of their care .
Amazon , JPMorgan , and Berkshire oversee(#overlap 2020-05-11 16:40:00) healthcare for about 1 million people and spend(#before 2020-05-11 16:40:00) $ 4 billion a year on healthcare for about 1 million people .
At the time , news of a healthcare joint venture that 's geared toward lowering healthcare costs for the companies ' employees and improving the quality of their care sent(#before 2020-05-11 16:40:00) healthcare stocks plummeting(#before 2020-05-11 16:40:00) , especially for health insurers and members of the pharmaceutical supply chain that might be affected(#before 2020-05-11 16:40:00) by Amazon , JPMorgan , and Berkshire getting(#before 2020-05-11 16:40:00) into Amazon , JPMorgan , and Berkshire lines of work .
While Haven has n't been too specific about how Haven plans(#before 2020-05-11 16:40:00) to upend(#after 2020-05-11 16:40:00) the healthcare system , details did come(#included 2019) out through a 2019 lawsuit filed in Massachusetts against a former Optum employee who joined the venture .
Testimony in the case from Stoddard provided(#before 2020-05-11 16:40:00) new information about the Amazon-JPMorgan-Berkshire Hathaway health venture plans .
Testimony in the case from Stoddard was unsealed(#included Friday) after a motion brought(#before 2020-05-11 16:40:00) by the parent companies of the news site Stat and The Wall Street Journal .
